Astellas is turning innovative science into VALUE for patients at the Astellas Biomedical Innovation Hub in greater Boston, where one of the world’s most experienced teams of scientists, partners and pioneers is working to develop therapeutics in the most promising areas of medicine, science and research.
Astellas is deeply invested in leveraging collaborations with universities, academic medical centers, venture investors and biotechnology leaders. These partnerships enable Astellas to engage with cutting edge scientific expertise and unique technologies that have breakthrough potential in treating diseases.
This collaborator model, along with three results-driven attributes, positions the Astellas Biomedical Innovation Hub to translate emerging science into novel treatments for patients.
Astellas scientists have the flexibility to follow the science and pursue out-of-the box thinking to achieve the broadest potentials and ensure the most valuable outcomes for patients.
Freedom to Innovate
Astellas scientists have the independence to innovate with local decision-making by those who are closest to the science and discoveries they uncover.
Astellas builds on established expertise and scientific teams which are fueled with the focus, structure and collaborators needed for success.
More than 250 Astellas professionals at sites in Cambridge and Westborough are combining an in-depth understanding of the underlying biology of diseases with innovative platforms and treatment modalities.
Astellas Biomedical Innovation Hub’s Introductory Video
This video introduces Astellas Biomedical Innovation Hub, through which we pursue the most promising areas of biotechnology research, including regenerative medicine and mitochondrial biology.
Astellas Institute for Regenerative Medicine
At the Forefront of Cell Therapies
AIRM Building Dedication Highlights Video
This video introduces the voice of science luminaries, government and industry leaders marking the occasion of the Building Dedication of the Astellas Institute for Regenerative Medicine.
Scientists at the Astellas Institute for Regenerative Medicine (AIRM) are investigating pluripotent stem cell-derived therapies that have the potential to rejuvenate, regenerate and replace damaged tissues. Research, development, and manufacturing teams are closely collaborating to accelerate the realization of cell therapy.
Mitochondrial Biology and Beyond
Mitobridge is discovering and developing novel therapeutics that improve mitochondrial function and is expanding its deep biology-based approach to other disease pathways with high potential for therapeutic impact. You can see detail about Mitobridge.
Astellas Innovation Management
Partnering with Purpose
Astellas Innovation Management (AIM) is focused on promoting the intake of early-stage innovation into Astellas by actively seeking and evaluating collaboration opportunities that complement our innovation and business strategies. AIM has robust and wide-spread networks in the healthcare industry and has a flexible approach to partnering structures. You can learn how to partner with Astellas.
Learn about the Primary Focuses in AIRM and Mitobridge
Astellas is building a pipeline of therapeutic programs through its work at AIRM and Mitobridge that support our Primary Focuses of Blindness and Regeneration and Mitochondrial Biology.
Astellas Institute for Regenerative Medicine (AIRM)
9 Technology Drive
Westborough, MA 01581, USA
+1 508 756 1212
Mitobridge and Astellas Innovation Management LLC
1030 Massachusetts Avenue
Cambridge, MA 02138 USA
+1 617 401 9100